Dr. Richard Eldon Royal, MD

Dr. Royal practices at MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth.

Dr. Royal's NPI, 1598901316, was assigned on December 29, 2008. Dr. Royal graduated from Oregon Health Sciences University School of Medicine in 1988. Dr. Royal holds Maine license MD23049.

Dr. Royal's primary practice is MaineHealth Maine Medical Center, at 22 Bramhall St, Portland, ME 04102 in Cumberland County. The practice phone is (207) 662-0111.

Dr. Royal's primary practice is MaineHealth Maine Medical Center in Portland, Maine, part of MaineHealth. Dr. Royal is also affiliated with Northern Light Mercy Hospital. The medical group on file is MaineHealth Primary Care - Family Medicine - Portland. Dmand AI also links Dr. Royal to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Royal practices, 6 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Royal's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Royal is licensed in Maine.

CMS data shows 370 Medicare services from Dr. Royal across 9 procedure codes in 2024, for 187 Medicare patients. Medicare paid $33,500 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 187 Medicare patients who saw Dr. Royal in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Royal's median patient age at 72, with 41% women.

In 2024, Dr. Royal wrote 133 Medicare Part D claims for 87 patients. 96% of them were for generic drugs. CMS names the drug for 76 of them, across 2 drugs with 11 or more claims each, at $519 in total drug cost. In 2023, CMS named 53 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Royal for performance year 2024, reported through an alternative payment model (APM). Dr. Royal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Royal as offering telehealth. CMS counts 74 procedures of melanoma (skin cancer) excision by Dr. Royal, more than 90% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 27 papers to Dr. Royal, published from 2014 to 2025. 2015 was the busiest year, with 4. The most frequent topics are Melanoma, Antineoplastic Combined Chemotherapy Protocols and Cytoreduction Surgical Procedures. Dr. Royal has published most often in Ann Surg Oncol. Dr. Royal's most frequent co-authors are Keith Francis Fournier, MD, Jeffrey E. Gershenwald, MD and Anthony P. Lucci, MD.

CMS Open Payments shows 2 general payments to Dr. Royal from 2 drug and device companies from 2016 to 2020. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $109.

Dr. Royal graduated from Oregon Health Sciences University School of Medicine in 1988.